Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2025-02-27 Investor Presentation
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Updated Company Presentation and Shareholder Webinar 27 pages 15.3MB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 28 February 2025 from Biome Australia Limited. It announces an updated company presentation and a shareholder webinar scheduled for 7 March 2025. The text includes a detailed company presentation with business highlights, strategy, product information, and growth plans. The presentation is intended for investors and includes forward-looking statements and disclaimers. There is no indication that this is a full financial report such as an Annual Report (10-K) or Interim Report (IR). It is not a regulatory filing, earnings release, or other specific report type. The document is primarily a detailed investor presentation and announcement of a webinar to discuss half yearly results, which aligns with the definition of an Investor Presentation (IP). The length and content support this classification with high confidence.
2025-02-27 English
Appendix 4D & Half Yearly Report 20 pages 570.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Biome Australia Limited Appendix 4D Half-year report' and references the half-year ended 31 December 2024. It contains detailed financial statements including profit and loss, financial position, cash flows, notes to the financial statements, and directors' report. It also includes an auditor's review report and independence declaration. The content is comprehensive and covers the company's financial performance and position for the half-year period, which aligns with the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2025
2025-02-17 English
Biome First Half FY25 Results and Highlights 8 pages 632.1KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 18 February 2025, titled 'Biome First Half FY25 Results and Highlights'. It contains detailed financial results for the half year ended 31 December 2024, including net profit, EBITDA, sales revenue, gross margin, and business highlights. The document includes forward-looking statements and strategic plans for the next three years. The presence of comprehensive financial data and analysis for a half-year period indicates this is a half-year financial report. The document is over 11,000 characters, so it is not a mere announcement of a report but the report itself. The content matches the characteristics of an Interim / Quarterly Report (IR) rather than a brief earnings release or investor presentation. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2025
2025-02-17 English
Biome Secures FaBA Co-investment for IP Development 4 pages 295.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 5 February 2025, detailing a new co-investment agreement between Biome Australia Limited and the Food and Beverage Accelerator (FaBA) for intellectual property development. It discusses the terms of the partnership, funding arrangements, and the strategic importance of the collaboration for Biome's product development pipeline. There are no financial statements, quarterly or annual results, nor is this a transcript, audit report, or regulatory filing. The content focuses on a capital/financing update related to funding and partnership agreements for R&D. The document length is 8119 characters, which is substantive and not a mere announcement of a report publication. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-02-04 English
Positive Results on Clinical Development of BMB18 5 pages 362.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 30 January 2025 providing positive results on clinical development of a probiotic strain BMB18 by Biome Australia Limited. It details scientific study findings, potential clinical applications, and includes commentary from the Managing Director. The document is an update on research progress and does not contain financial statements, earnings data, regulatory certifications, or voting results. It is not a full annual or interim report, nor a call transcript or capital update. It is a corporate announcement about research progress and product development. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-01-29 English
Biome Increases Australian Distribution 4 pages 4.5MB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 23 January 2025, detailing Biome Australia Limited's increase in distribution locations for its products. It includes growth statistics, new deals, product information, and forward-looking statements. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a business update on distribution growth and market presence, typical of a capital or operational update rather than a formal financial report or regulatory filing. The document length is 6715 characters, which is sufficient for a detailed announcement but does not contain financial data or detailed investor presentation slides. It is not an earnings release or annual/interim report. The nature of the content aligns best with a Capital/Financing Update (CAP) as it discusses expansion and growth in distribution footprint, which is a form of operational capital update relevant to investors and the market.
2025-01-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.